Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU


Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1375

PDF Downloaded: 663


Brief review on recent outcomes of applications of green synthesis vs chemical synthesis of silver nanoparticles


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Kirti Rani*

Volume : 5, Issue : 1, Year : 2020

Article Page : 9-13

https://doi.org/10.18231/j.ijcaap.2020.003



Suggest article by email

Get Permission

Abstract

Silver nanoparticles (AgNP) have been already proposed for many advanced research approaches in the fields of therapeutics and nanomedicine due to their non-antigenicity and more potent optical characteristics along with their respective antioxidant and antimicrobial properties in effective site specific targeted drug-delivery practices systems. In last few years, chemically synthesized metal based nanoparticles has been studies for their biological and delivery behaviours because of use of various chemical and bio-hazardous chemicals in their preparations. Various previous studies on green synthesis of silver metal based nanoparticles have been designed which involved biological sources like microorganisms, plants and herbal extracts as cost effective, eco-friendly and non-toxic approaches. So that, green synthesis of silver nanoparticles has been much exploited in wider range of applications in the field of biomedical, therapeutics, nanomedicine and pharmaceuticals as more potent and safe drug delivery vehicles as compared to chemically preparations of silver nanoparticles. Therefore, in this review, we recollected the comparative studies based on advantages of green approaches of silver nanoparticles over their respective chemical preparations.

Keywords: Silver nanoparticles, Green synthesis, Therapeutics, Nanomedicine, Drug delivery vehicles.



How to cite : Rani K, Brief review on recent outcomes of applications of green synthesis vs chemical synthesis of silver nanoparticles. IP Int J Compr Adv Pharmacol 2020;5(1):9-13


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.